ETF overview
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
Fund facts
- Expense ratio
- 0.35%
- Fund assets
- 10.42B USD (all share classes)
- Issuer
- SPDR
- Inception date
- Jan 31, 2006
- Number of holdings
- 166
Breakdown
Holdings (166)
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 2.64% |
| NATERA INC | NTRA | 1.85% |
| TWIST BIOSCIENCE CORP | TWST | 1.74% |
| HALOZYME THERAPEUTICS INC | HALO | 1.71% |
| ABBVIE INC | ABBV | 1.71% |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | 1.69% |
| BIOGEN INC | BIIB | 1.69% |
| AMGEN INC | AMGN | 1.68% |
| GILEAD SCIENCES INC | GILD | 1.63% |
| EXELIXIS INC | EXEL | 1.63% |
| and 153 more | ||
Similar ETFs
- Virtus Biotech ETFBBP · Overlap 48% · Expense ratio 0.34%
- iShares Biotechnology ETFIBB · Overlap 44% · Expense ratio 0.44%
- Invesco Nasdaq Biotechnology ETFIBBQ · Overlap 43% · Expense ratio 0.19%
- Invesco NASDAQ Biotech UCITS ETFSBIO.L · Overlap 43% · Expense ratio 0.40%
- iShares Nasdaq US Biotechnology UCITS ETFBTEC.L · Overlap 43% · Expense ratio 0.35%
- MiraeAsset TIGER NASDAQ BIO ETF203780.KS · Overlap 43% · Expense ratio 0.30%
- Invesco Biotechnology & Genome ETFPBE · Overlap 30% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
- Expense ratio
- 0.35%
- Fund assets
- 10.42B USD (all share classes)
- Issuer
- SPDR
- Inception date
- Jan 31, 2006
- Number of holdings
- 166
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 2.64% |
| NATERA INC | NTRA | 1.85% |
| TWIST BIOSCIENCE CORP | TWST | 1.74% |
| HALOZYME THERAPEUTICS INC | HALO | 1.71% |
| ABBVIE INC | ABBV | 1.71% |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | 1.69% |
| BIOGEN INC | BIIB | 1.69% |
| AMGEN INC | AMGN | 1.68% |
| GILEAD SCIENCES INC | GILD | 1.63% |
| EXELIXIS INC | EXEL | 1.63% |
| and 153 more | ||
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
- Virtus Biotech ETFBBP · Overlap 48% · Expense ratio 0.34%
- iShares Biotechnology ETFIBB · Overlap 44% · Expense ratio 0.44%
- Invesco Nasdaq Biotechnology ETFIBBQ · Overlap 43% · Expense ratio 0.19%
- Invesco NASDAQ Biotech UCITS ETFSBIO.L · Overlap 43% · Expense ratio 0.40%
- iShares Nasdaq US Biotechnology UCITS ETFBTEC.L · Overlap 43% · Expense ratio 0.35%
- MiraeAsset TIGER NASDAQ BIO ETF203780.KS · Overlap 43% · Expense ratio 0.30%
- Invesco Biotechnology & Genome ETFPBE · Overlap 30% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free